SLS

SELLAS LIFE SCIENCES GROUP I

SLS·81642T209·US·Common Stock·Healthcare - Biotechnology-13D/G

SLS (SELLAS LIFE SCIENCES GROUP I) is held by 87 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($51.6M), STATE STREET CORP ($35.5M), VANGUARD CAPITAL MANAGEMENT LLC ($31.8M). Net institutional sentiment: Bullish.

87
Holders
Avg rating(24 Elite)
$213.1M
Total Value
81% (94)
Fund Consensus
74 buying - 17 selling
SLSSmart Money Verdict
View all
Held by 87 funds
24 elite
Who's Trading
ActivistBlackRock, Inc.BlackRock, Inc.6.8%Apr 24, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistANAnson Funds Management LP4.9%Feb 17, 2026
ActivistHIHighbridge Capital Management, LLC3.7%Jan 30, 2026
InsiderKBKalin Katherine BachBuy $101KNov 19, 2025
InsiderVLVAN NOSTRAND ROBERT LBuy $15KJun 12, 2025
InsiderWJWasman JaneBuy $34KMay 30, 2025
InsiderKBKalin Katherine BachBuy $36KMay 22, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.2M(+61.8%)$51.6M0.0%+279.41%
42
Increased
8.4M(+283.7%)$35.5M0.0%+181.75%
47
New
7.5M$31.8M0.0%+140.30%
40
Increased
3.9M(+27.1%)$16.6M0.0%+315.04%
35
Increased
2M(+52.0%)$8.6M0.0%+312.09%
38
Increased
1.7M(+290.2%)$7.3M0.0%+166.00%
44
New
1.5M$6.2M0.0%+140.30%
38
Increased
1.3M(+50.0%)$5.7M0.0%+320.18%
37
Increased
1.3M(+37.1%)$5.4M0.0%+316.44%
35
New
1.2M$5.1M0.0%+140.30%
37
Increased
745,419(+1429.8%)$3.2M0.0%+151.29%
43
Increased
698,080(+1209.9%)$3M0.0%+152.20%
43
Decreased
670,974(-34.5%)$2.8M0.0%+546.24%
0
Increased
641,683(+535.7%)$2.7M0.0%+160.38%
42
Increased
555,913(+35.0%)$2.4M0.0%+237.40%
34
Increased
480,604(+17.7%)$2M0.0%+358.45%
30
Increased
478,366(+86.6%)$2M0.0%+249.61%
40
Decreased
403,165(-62.8%)$1.7M0.0%+311.75%
0
Increased
397,056(+13.5%)$1.7M0.0%+535.39%
29
New
344,778$1.5M0.0%+140.30%
35

Showing 1-20 of 94

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used